
NuVasive NUVA
Quarterly report 2023-Q2
added 08-02-2023
NuVasive Operating Cash Flow 2011-2026 | NUVA
Annual Operating Cash Flow NuVasive
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 169 M | 182 M | 186 M | 235 M | 219 M | 177 M | 158 M | - | - | 97.4 M | 130 M | 63 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 235 M | 63 M | 162 M |
Quarterly Operating Cash Flow NuVasive
| 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | 1.97 M | - | 122 M | - | 6.54 M | - | 145 M | - | 31.6 M | - | 113 M | 33.1 M | 5.22 M | - | 161 M | 93.4 M | 24.5 M | - | 150 M | 77.2 M | 36.4 M | - | 119 M | 67.1 M | - | - | - | - | - | - | - | - | - | - | - | - | 23.3 M | - | 70.1 M | 32.4 M | 24.1 M | - | 99.5 M | 65.8 M | 39.7 M | - | 53.4 M | 27.7 M | 14.5 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 161 M | 1.97 M | 63 M |
Operating Cash Flow of other stocks in the Medical devices industry
| Issuer | Operating Cash Flow | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Allied Healthcare Products
AHPI
|
-4.1 M | - | 3.58 % | $ 2.21 M | ||
|
Apollo Endosurgery
APEN
|
-31.3 M | - | - | $ 475 M | ||
|
Alphatec Holdings
ATEC
|
45.2 M | - | - | $ 1.05 B | ||
|
EDAP TMS S.A.
EDAP
|
-13.6 M | $ 3.6 | 4.2 % | $ 135 M | ||
|
Aziyo Biologics
AZYO
|
-44.8 M | - | 1.37 % | $ 20.5 M | ||
|
Avinger
AVGR
|
-14.4 M | - | -20.74 % | $ 369 K | ||
|
Axonics Modulation Technologies
AXNX
|
3.19 M | - | - | $ 3.31 B | ||
|
BioSig Technologies
BSGM
|
-10.4 M | - | 37.08 % | $ 85.7 M | ||
|
BIOLASE
BIOL
|
-14.1 M | - | -13.19 % | $ 166 K | ||
|
Helius Medical Technologies
HSDT
|
-10.4 M | $ 2.22 | 2.78 % | $ 1.35 M | ||
|
Conformis
CFMS
|
-50.2 M | - | - | $ 16.4 M | ||
|
ClearPoint Neuro
CLPT
|
-23.9 M | $ 11.47 | 3.33 % | $ 325 M | ||
|
Cardiovascular Systems
CSII
|
-24.3 M | - | 0.15 % | $ 844 M | ||
|
OrthoPediatrics Corp.
KIDS
|
-4.85 M | $ 17.12 | 0.47 % | $ 402 M | ||
|
Cytosorbents Corporation
CTSO
|
-12.4 M | $ 0.57 | -5.8 % | $ 35.5 M | ||
|
LivaNova PLC
LIVN
|
254 M | $ 66.26 | 15.05 % | $ 3.61 B | ||
|
Delcath Systems
DCTH
|
22.5 M | $ 11.26 | -2.34 % | $ 403 M | ||
|
Neovasc
NVCN
|
-27.1 M | - | - | $ 111 M | ||
|
IRIDEX Corporation
IRIX
|
-2.12 M | $ 1.04 | -0.95 % | $ 17.6 M | ||
|
Dynatronics Corporation
DYNT
|
301 K | - | 14.99 % | $ 929 K | ||
|
Eargo
EAR
|
-117 M | - | - | $ 10.2 M | ||
|
Electromed
ELMD
|
11.4 M | - | 0.5 % | $ 219 M | ||
|
Myomo
MYO
|
-14.5 M | $ 0.85 | -2.78 % | $ 35.6 M | ||
|
Butterfly Network
BFLY
|
-41.7 M | $ 4.55 | -5.6 % | $ 963 M | ||
|
Second Sight Medical Products
EYES
|
-24.3 M | - | -0.97 % | $ 54.4 M | ||
|
Orthofix Medical
OFIX
|
33.3 M | $ 12.19 | -2.01 % | $ 483 M | ||
|
Insulet Corporation
PODD
|
569 M | - | - | $ 10.6 B | ||
|
GBS
GBS
|
-9.68 M | - | -0.57 % | $ 7.12 M | ||
|
Globus Medical
GMED
|
753 M | $ 89.22 | -0.9 % | $ 12.1 B | ||
|
Sintx Technologies
SINT
|
-8.57 M | $ 2.4 | -0.83 % | $ 6.66 M | ||
|
CONMED Corporation
CNMD
|
171 M | $ 37.32 | 1.86 % | $ 1.16 B | ||
|
Inspire Medical Systems
INSP
|
117 M | $ 45.7 | -5.42 % | $ 1.34 B | ||
|
Integer Holdings Corporation
ITGR
|
196 M | $ 86.29 | 0.51 % | $ 3 B | ||
|
Invacare Corporation
IVC
|
-55.3 M | - | - | $ 24.7 M | ||
|
Stryker Corporation
SYK
|
5.04 B | $ 292.33 | -0.99 % | $ 112 B | ||
|
Edwards Lifesciences Corporation
EW
|
1.6 B | $ 83.2 | 0.35 % | $ 48.7 B | ||
|
TransMedics Group
TMDX
|
193 M | - | - | $ 2.48 B | ||
|
Tactile Systems Technology
TCMD
|
42.8 M | $ 25.3 | 5.2 % | $ 579 M | ||
|
Tandem Diabetes Care
TNDM
|
-9.72 M | - | - | $ 1.23 B | ||
|
LENSAR
LNSR
|
-14.8 M | $ 5.39 | -1.73 % | $ 64.5 M |